BioNTech’s chief executive has said he is confident the Covid-19 vaccine his company pioneered with Pfizer will work against a new variant circulating in India, where health officials are recording hundreds of thousands of new coronavirus cases a day.
BioNTech首席执行官乌尔•沙欣 (Ugur Sahin)表示，他有信心认为该公司与辉瑞(Pfizer)共同研发的疫苗将对印度出现的新变种有效。目前印度卫生官员每日录得数十万例新增新型冠状病毒肺炎（COVID-19，即2019冠状病毒病）病例。
您已阅读7%（375字），剩余93%（5338字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。